Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Flow-controlled versus volume-controlled breathing during one-lung ventilation

Official title: Comparison of the Effects of Flow-Controlled Ventilation (FCV) and Volume-Controlled Ventilation (VCV) on Respiratory Mechanics and Gas Exchange During One-Lung Ventilation: A Multicenter Prospective Observational Study (FCVOLVent)

Run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · NCT07392086 · Data updated 2026-11-12

This project tests whether flow-controlled ventilation (FCV) or standard volume-controlled ventilation (VCV) gives better lung mechanics and oxygenation in adults having one-lung ventilation for thoracic surgery.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Academic / other
Locations1 site (Ankara, Yenimahalle)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJuly 30, 2026
Study endsDecember 1, 2026
Registry record updatedFebruary 6, 2026
Trial IDNCT07392086 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older undergoing elective thoracic surgery that requires at least 30 minutes of one-lung ventilation, with ASA physical status I–III and able to give informed consent are the intended participants.

Probably not a fit

Patients requiring emergency surgery or those with severe pulmonary or cardiac risk factors (e.g., severe COPD, very low predicted postoperative FEV1, advanced cardiomyopathy), high BMI, active pulmonary infection, or other excluded conditions are unlikely to benefit or are not eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, prospective observational comparison of FCV and VCV in adult patients undergoing thoracic surgery requiring one-lung ventilation. Patients receive the ventilation mode routinely used at their center (FCV or VCV) without randomization or additional interventions. Intraoperative respiratory mechanics (dynamic compliance, airway and driving pressures) and arterial blood gas measures including PaO2/FiO2 are recorded and compared between groups. Secondary data include other oxygenation variables and perioperative respiratory events.

Why it matters

Potential benefit: If FCV shows better mechanics and oxygenation, it could reduce intraoperative lung stress and improve oxygen levels during thoracic surgery.

How similar studies have gone: Previous experimental work and limited clinical reports suggest FCV may improve lung recruitment and gas exchange compared with conventional modes, but evidence is still limited and not widely confirmed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Adult patients aged 18 years and older Patients undergoing thoracic surgery requiring one-lung ventilation (OLV) Requirement for one-lung ventilation for at least 30 minutes American Society of Anesthesiologists (ASA) physical status I-III Provision of written informed consent Patients ventilated with flow-controlled ventilation (FCV) or volume-controlled ventilation (VCV) as part of routine clinical practice

Exclusion Criteria Requirement for emergency surgery History of untreated asthma High pulmonary risk, defined as predicted postoperative FEV₁ \< 20 mL/kg in males and \< 18 mL/kg in females High cardiac risk, including advanced cardiomyopathy with left ventricular ejection fraction \< 30% Body mass index (BMI) \> 35 kg/m² Contraindication to total intravenous anesthesia (TIVA) Evidence of pulmonary infection prior to surgery Presence of other significant pulmonary pathologies (e.g., tuberculosis, bullous lung disease, bronchiectasis) Severe COPD (GOLD stage III-IV) or significant restrictive lung disease Age \< 18 years or \> 80 years, or pregnancy ASA physical status IV or higher Uncontrolled arrhythmia or history of myocardial infarction within the past 3 months Inability to provide informed consent

Where it's running

  • Health Sciences University Dr. Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital
    Ankara, Yenimahalle, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.